US 8778608
CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma
granted A61PA61P35/00A61P35/04
Quick answer
US patent 8778608 (CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma) held by The Regents of the University of California expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P35/04, A61P37/04